Evidence mapPaperPMID 41366269Full record

ArticleScientific reports2025

Comprehensive metabolites characterization of Alpinia katsumadai seeds via a multiplex approach of UHPLC-MS/MS and GC-MS techniques.

Nermeen B Ali, Mai E Hussein, Mohamed A Farag

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nermeen B AliDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini St, Cairo, 11562, Egypt. Nermeen.ali@pharma.cu.edu.eg.
Mai E HusseinDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini St, Cairo, 11562, Egypt.
Mohamed A FaragDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini St, Cairo, 11562, Egypt. mohamed.farag@pharma.cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpinia katsumadai Hayata (Zingiberaceae) is an edible seed valued in traditional medicine for its remarkable therapeutic properties. The seed serves as a fragrant culinary spice, adding a unique flavor to various foods. In this study, three approaches were employed to elucidate seed metabolome including UHPLC-MS/MS-based molecular networking, HS-SPME/GC-MS, and post-silylation GC-MS. A total of 82 secondary metabolites spanning diverse chemical classes were annotated, including the report of two newly annotated catechin-guibourtinidol derivatives and deoxy phloretin-3'-C-hexoside for the first time in Alpinia genus, alongside the first hypothesis of calyxins' class mass fragmentation pattern. HS-SPME/GC-MS analysis led to the detection of 30 aroma determinants dominated by sesquiterpenes (55.1%) and monoterpenes (36.8%). Daucene and α-phellandrene were detected at 274.41 µg/g and 161.25 µg/g, respectively, and to likely account for seed aroma. GC-MS post-silylation dissected 48 metabolites, revealing the abundance of sugars, arylheptanoids, and flavonoids, with sucrose as major sugar (23.81 mg/g), and cardamonin, as major flavonoid. Such comprehensive phytochemical mapping provides critical insights into A. katsumadai seed metabolome, offering novel evidence for its health-promoting and culinary qualities.

Indexed as

AlpiniaMetabolomeMetabolomicsSeedsChromatography, High Pressure LiquidGas Chromatography-Mass SpectrometryTandem Mass SpectrometryAlpinia katsumadai hayataMolecular networkingSilylated GC–MSSolid-phase micro-extraction (SPME)UHPLC–MS/MSZingiberaceae

Identifiers

PMID41366269
PMCPMC12689793

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.